Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00661_DB06695> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00661_DB06695 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00661_DB06695 label "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered. [drugbank_resource:DB00661_DB06695]" assertion.
- drugbank_resource:DB00661_DB06695 identifier "drugbank_resource:DB00661_DB06695" assertion.
- drugbank_resource:DB00661_DB06695 title "DDI between Verapamil and Dabigatran etexilate - Verapamil may increase serum concentrations of the active metabolite(s) of dabigatran etexilate, resulting in an increased risk of bleeding. It is also a strong p-glycoprotein inhibitor. Therapy modification should be considered." assertion.